Skip to main content

Table 1 Differentially expressed proteins identified by MS after 2-DE

From: Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma

Spot No.

Protein Name

Accession Number (NCBI)

MW(Da)

pI

MASCOT score

Total Ion Score C.I. %

Location

S7

fibrinogen gamma chain

gi|119625323

37714

5.87

177

100

T1,T2

S8

fibrinogen beta chain

gi|119625344

39711

6.95

137

100

T1,T2

S9

lactate dehydrogenase B

gi|119616854

36615

5.71

104

99.9988

T1,T2

S10

Apo-A1

gi|490098

28061

5.27

235

100

T1,T2

S11

Apo-A1

gi|490098

28061

5.27

207

100

T1,T2

S12

Clusterin

gi|42740907

52461

5.89

102

99.9565

T1,T2

S13

hp2-alpha

gi|296653

41499

6.25

115

98.9869

T1,T2

S16

fibrinogen gamma chain

gi|119625325

35480

6.07

100

100

T1

  1. T1: the protein expression increased in urine samples from patients with low malignant BTCC;
  2. T2: the protein expression increased in urine samples from patients with aggressive BTCC.